On June 1, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following virtual conferences in June (Press release, Iovance Biotherapeutics, JUN 1, 2021, View Source [SID1234583316]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Healthcare Conference
Fireside Chat: Tuesday, June 1 at 3:30 p.m. ET
Goldman Sachs 42nd Annual Global Healthcare Conference
Fireside Chat: Wednesday, June 9 at 5:30 p.m. ET
JMP Securities Life Sciences Conference
Fireside Chat: Thursday, June 17 at 2:00 p.m. ET
The live and archived webcasts of the presentations will be available in the Investors section of the Iovance website at View Source